These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. DuSell CD; Nelson ER; Wang X; Abdo J; Mödder UI; Umetani M; Gesty-Palmer D; Javitt NB; Khosla S; McDonnell DP Endocrinology; 2010 Aug; 151(8):3675-85. PubMed ID: 20501668 [TBL] [Abstract][Full Text] [Related]
8. Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol. Nelson ER Methods Mol Biol; 2016; 1366():431-443. PubMed ID: 26585155 [TBL] [Abstract][Full Text] [Related]
9. The estrogen receptor as a mediator of the pathological actions of cholesterol in breast cancer. McDonnell DP; Chang CY; Nelson ER Climacteric; 2014 Dec; 17 Suppl 2(0 2):60-5. PubMed ID: 25320023 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol and breast cancer pathophysiology. Nelson ER; Chang CY; McDonnell DP Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418 [TBL] [Abstract][Full Text] [Related]
11. 27-Hydroxycholesterol: the first identified endogenous SERM. Umetani M; Shaul PW Trends Endocrinol Metab; 2011 Apr; 22(4):130-5. PubMed ID: 21353593 [TBL] [Abstract][Full Text] [Related]
12. Obesity, cholesterol metabolism, and breast cancer pathogenesis. McDonnell DP; Park S; Goulet MT; Jasper J; Wardell SE; Chang CY; Norris JD; Guyton JR; Nelson ER Cancer Res; 2014 Sep; 74(18):4976-82. PubMed ID: 25060521 [TBL] [Abstract][Full Text] [Related]
13. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. Raza S; Ohm JE; Dhasarathy A; Schommer J; Roche C; Hammer KD; Ghribi O Mol Cell Biochem; 2015 Dec; 410(1-2):187-95. PubMed ID: 26350565 [TBL] [Abstract][Full Text] [Related]
14. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link. Asghari A; Umetani M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650428 [TBL] [Abstract][Full Text] [Related]
15. The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. Zhu D; Shen Z; Liu J; Chen J; Liu Y; Hu C; Li Z; Li Y Toxicol Lett; 2016 Dec; 264():79-86. PubMed ID: 27856279 [TBL] [Abstract][Full Text] [Related]
16. 27-Hydroxycholesterol Is an Estrogen Receptor β-Selective Negative Allosteric Modifier of 17β-Estradiol Binding. Starkey NJE; Li Y; Drenkhahn-Weinaug SK; Liu J; Lubahn DB Endocrinology; 2018 May; 159(5):1972-1981. PubMed ID: 29579190 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Katzenellenbogen BS; Katzenellenbogen JA Breast Cancer Res; 2000; 2(5):335-44. PubMed ID: 11250726 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial. Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467 [TBL] [Abstract][Full Text] [Related]
19. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Umetani M; Domoto H; Gormley AK; Yuhanna IS; Cummins CL; Javitt NB; Korach KS; Shaul PW; Mangelsdorf DJ Nat Med; 2007 Oct; 13(10):1185-92. PubMed ID: 17873880 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer and (25R)-26-hydroxycholesterol. Javitt NB Steroids; 2015 Dec; 104():61-4. PubMed ID: 26299212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]